Scientific Output

Scientific Output

This is the publication archive. For current publications please visit the publication overview.

2009
  1. Attard G, A’Hern R, Swennenhuis JF, Reid AHM, Olmos D, Vickers E, Levink R, Coumans F, Moreira J, Riisnaes R, Carden CP, Oomen NB, Hawche G, Jameson C, Thompson E, Sipkema R, Parker C, Dearnaley D, Kaye SB, Cooper CS, Molina A, Cox ME, Leon MW Terstappen LWMM, de Bono JS. Molecular Characterization of Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer. Cancer Research In Press.
  2. Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LWMM, Meropol NJ. Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer Annals of Oncology In Press.
  3. J. Wind, J.B. Tuynman, A.G.J. Tibbe, J.F. Swennenhuis, D.J. Richel, M.I. van Berge Henegouwen, W.A. Bemelman Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood EJCO 2009
  4. D Olmos, HT Arkenau, JE Ang, I Ledaki, G Attard, CP Carden, AHM Reid, RA Hem, PC Fong, NB Oomen, R Molife, D Dearnaley, C Parker, LWWM Terstappen, JS DeBono. Circulating Tumor Cells (CTC) as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Annals of Oncology August 11, 2008. [Epub ahead of print]
  5. X Li, C Breukers, A Ymeti, B Lunter, LWMM. Terstappen, J Greve. CD4 and CD8 Enumeration for HIV Monitoring in Resource-Constrained Settings. Cytometry Part B 2008 Sep 29. [Epub ahead of print]
  6. Olmos D, Arkenau HT, Ang JE, Ledaki I, Attard G, Carden CP, Reid AHM, Hem RA, Fong PC, Oomen NB, Molife R, Dearnaley D, Parker C, Terstappen LWWM, DeBono JS. Circulating Tumor Cells (CTC) as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Annals of Oncology 20: 27-37,2009.
  7. Li X, Breukers C, Ymeti A, Lunter B, Terstappen LWMM., Greve J. CD4 and CD8 Enumeration for HIV Monitoring in Resource-Constrained Settings. Cytometry 76B: 118-126, 2009.
  8. Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LWMM, Meropol NJ. Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer Annals of Oncology 20: 1223-1229, 2009.
  9. Attard G, Swennenhuis JF, Olmos D, Reid AHM, Vickers E, A’Hern R, Levink R, Coumans F, Moreira J, Riisnaes R, Oomen NB, Hawche G, Jameson C, Thompson E, Sipkema R, Carden CP, Parker C, Dearnaley D, Kaye SB, Cooper CS, Molina A, Cox ME, Terstappen LWMM, de Bono JS. Characterization of ERG, AR and PTEN status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer. Cancer Research 69: 2912-2918, 2009.
  10. Swennenhuis JF, Tibbe AGJ, Levink R, Sipkema RCJ, Terstappen LWMM. Characterization of Circulating Tumor Cells by Fluorescence In-Situ Hybridization. Cytometry Part A 75A: 520-527, 2009.
  11. Connelly M, Wang Y, Doyle GV, Terstappen L, McCormack R. Commentary The molecular characterization of 19 breast cancer cell lines by Sieuwerts et al. JNCI, 101: 895, 2009.
  12. Miller MC, Gerald V Doyle GV, Leon WMM Terstappen LWMM. Significance of Circulating Tumor Cells detected by the CellSearch® System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncology Vol 2010, Article ID 617421, 1-8, 2009.
  13. Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Gualberto A. Safety, Pharmacokinetics and Pharmacodynamics of the IGF-IR Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin. Journal of Thoracic Oncology 4(11), 1397-1403, 2009.
  14. Pully, V.V. Lenferink, A., Otto, C., (2010) Hybrid Rayleigh-, Raman and TPE fluorescence spectral confocal microscopy of living cells. Acc. by JRS aug 2009
  15. Manen, H.W.J. van, Otto, C., (2009) Cholesterol esters are detected by Raman microspectroscopy in HeLa cells, Journal of Raman Spectroscopy, 40(2), p.117-118.
  16. Chimento, P. Jurna, M., Korterik, J., Otto, C., Herek, J., Offerhaus, H.L. (2009) High resolution narrowband CARS spectroscopy in the spectral fingerprint region”. Journal of Raman Spectroscopy DOI 10.1002/jrs.2267
  17. Escalante-Marun, M., Blum, C., Cesa, Y. Otto, C., Subramaniam, V. (2009) “FRET-pair printing of fluorescent proteins”, Langmuir 25(12), p. 7019-7024
  18. Murade, C.U., Subramaniam, V., Otto, C., Bennink, M.L., (2009) “Interaction of oxazole yellow dyes with DNA studied with hybrid optical tweezers and fluorescence microscopy” Biophysical Journal 97, p. 835-843.
  19. Pully, V.V., Otto, C. (2009) “The Intensity of the 1602 cm-1-band in Human Cells is related to Mitochondrial Activity” Journal of Raman Spectroscopy, 40(5), p. 473-475.
  20. Jurna, M. Korterik, J.P., Otto, C., Herek, J.L., Offerhaus, H.L. (2009) “Vibrational Phase Contrast Microscopy by use of Coherent anti-Stokes Raman Scattering” Physical Review Letters, 103, 043905.
  21. Wu, C.C., Xu, H., Otto, C., Reinhoudt, D.N., Lammertink, R.G.H., Huskens, J., Subramaniam, V., Velders, A.H. (2009) “Porous multi-layer-coated AFM tips for Dip-Pen Nanolithography of proteins”, JACS Communications 131, p. 7526-7527
  22. Vaandrager, B., Testerink, N., Ajat, M., Houweling, M., Brouwers, J.F.H.M., Pully, V.V., van Manen, H.W.J., Otto, C., Helms, J.B. (2009) Raman imaging and lipidomic analysis of lipid droplets in activated hepatic stellate cells. Chem. And Phys. Of lipids 160S, S1 – S17
  23. Blum, C., Mosk, A., Otto, C., Vos, W., Subramaniam, V., (2009) Spectral emission imaging to map photonic properties below the crystal surface of 3D photonic crystals. JOSA B, 26(11), 2101 - 2108
2008
  1. Steven J. Cohen, Cornelis J. A. Punt, Nicholas Iannotti, Bruce H. Saidman, Kert D. Sabbath, Nashat Y. Gabrail, Joel Picus, Michael Morse, Edith Mitchell, Christopher E. Desch, M. Craig Miller, Gerald V. Doyle, Henk Tissing, Leon W.M.M. Terstappen, and Neal J. Meropol The Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients with Metastatic Colorectal Cancer. JCO, 26:3213-3221, 2008.
  2. Craig Miller, Gerald V. Doyle, Leon W.M.M. Terstappen. Monitoring and characterization of Circulating Tumor Cells in Cancer Patients. AACR Education Book, 617-624, 2008.
  3. JS DeBono, HI Scher, RB Montgomery, C Parker, MC Miller, H Tissing, GV Doyle, LWWM Terstappen, KJ Pienta, D Raghavan Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC). Clin Can Res 14: 6302-6309, 2008.
  4. Strijbos MHRao CSchmitz PIKraan JLamers CHSleijfer STerstappen LWGratama JW. Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage. Thromb Haemost. 100:642-647, 2008.
2007
  1. Arjan G.J. Tibbe, Craig Miller, Leon W.M.M. Terstappen. Statistical Considerations for Enumeration of Circulating Tumor Cells. Cytometry Part A 71A: 154-162, 2007.
  2. Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, Connelly MC, Rao C, Terstappen. LWMM. Endothelial Cells in Peripheral Blood of Healthy Subjects and Patients with Metastatic Carcinomas. Cytometry Part A 71A: 105-113, 2007.
  3. Aurel Ymeti, Xiao Li, Björn Lunter, Christian Breukers, Arjan G.J. Tibbe, Leon W.M.M. Terstappen, Jan Greve. A Single Platform Image Cytometer for resource-poor settings to monitor disease progression in HIV infection. Cytometry Part A 71A: 132-142, 2007.
  4. Xiao Li, Arjan GJ Tibbe, Erik Droog, Leon WMM Terstappen, Jan Greve An Immuno-magnetic Single Platform Image Cytometer for Cell Enumeration Based on Antibody Specificity. Clinical and Vaccine Immunology 14: 412-419, 2007.
  5. David R. Shaffer, Margaret A. Leversha, Daniel C. Danila, Oscar Lin, Rita Gonzalez-Espinoza, Bin Gu, Aseem Anand, Jialian Han,2 Katherine Smith, Peter Maslak, Hans Lilja, Gerald Doyle, Leon WMM Terstappan, Glenn Heller, Martin Fleisher, Howard I. Scher Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer Clin Can Res 13: 2023-2029, 2007.
  6. Johann S de Bono, Gerhardt Attard, Alex Adjei, Michael N Pollak, Peter C Fong, Paul Haluska, Luisa Roberts, Carrie Melvin, Madeline Repollet, David Chianese, Mark Connely, Leon WMM Terstappen, Antonio Gualberto. Potential Applications for Circulating Tumor Cells expressing the Insulin Growth Factor-I Receptor. Clin Can Res 13: 3611-3616, 2007.
  7. Daniel R. Zweitzig, Denis A. Smirnov, Mark C. Connelly, Leon W. M. M. Terstappen, Elizabeth Moran, and S. Mark O’Hara. Regulation of AGR2 expression in response to serum starvation and hypoxia. Molecular and Cellular Biochemistry, 306:255-260, 2007.
2006
  1. Smirnov DA, Foulk BW, Gerald V. Doyle GV, Connelly MC, Terstappen LWMM, O’Hara SM Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Can Res. 66:2918-2922, 2006.
  2. Budd G, Cristofanilli M, Ellis M, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle G, Terstappen LWMM, Hayes D. Circulating Tumor Cells versus Imaging - Predicting Overall Survival in Metastatic Breast Cancer. Clin Can Res 12: 6404-6409,2006.
  3. Cohen SJ, Alpaugh RK, Gross S, O’Hara SM, Smirnov DA, Terstappen LWMM, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ. Isolation and Characterization of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer. Clin Colorectal Cancer 6: 125-132, 2006.
  4. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard JW, Doyle GV, Terstappen LWMM. Circulating tumor cells predict progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients. Clin Can Res 12:4218-4224, 2006.
  5. Xiao Li, Ymeti A, Lunter B, Breukers C, Tibbe AGJ, Terstappen LWMM, Greve J. CD4+ T Lymphocytes Enumeration by an Easy-to-use Single Platform Image Cytometer for HIV Monitoring in Resource-constrained Settings. Cytometry Part B 72B 397-407, 2007.
  6. Meng S, Tripathy D, Frenkel EP, Shete S, Ashfaq R, Saboorian H, Haley B, Frenkel E, Euhus D, Leitch M, Osborne C, Clifford E, Perkins S, Beitsch P, Kahn A, Morrison L, Herylyn D, Terstappen LWMM, Lane N, Wang J, Uhr JW. uPar and Her-2 gene status in individual breast cancer cells from blood and tissues. PNAS 103: 17361-17365, 2006

2005
  1. Moreno JG, Miller MC, Gross S, Allard WJ, Gomella LG, Terstappen LWMM. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology, 65: 713-718, 2005.
  2. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck AT, Doyle GV, Matera J, Allard WJ, Miller MC, Rueben JM, Fritsche HA, Hortobagyi GN, Terstappen LWMM Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer. JCO, 23: 1420-1430, 2005.
  3. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA, Terstappen LWMM. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int. J. Oncology, 27: 49-58, 2005.
  4. Smirnov DA, Zweitzig DR, Foulk BW, Doyle GV, Pienta KJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LWMM, O’Hara SM. Global Gene Expression Profiling of Circulating Tumor Cells. Can Res, 65: 4993-4997, 2005.
  5. Balic M, Dandachi N, Hofmann G, Samonigg H, Loibner H, Obwaller A, van der Kooi A, Tibbe A, Doyle GV, Terstappen LWMM, Bauernhofer T. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry Part B 68B: 25-30, 2005.
2004
  1. O'Hara SM, Moreno JG, Zweitzig DR, Gross G, Gomella LG, Terstappen LWMM. Multigene Reverse Transcription-PCR Profiling of Circulating Tumor Cells in Hormone-Refractory Prostate Cancer. Clin Chem, 50: 826-835, 2004.
  2. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Morrison L, Herlyn D, Terstappen LWMM, Fleming T, Fehm T, Tucker T, Lane N, Wang J, Uhr J. HER-2 Gene Amplification can be acquired as breast cancer progresses. PNAS, 101: 9393-9398, 2004.
  3. Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O’Hara SM, Russell T, Terstappen LWMM. Apoptosis of Circulating Tumor Cells in Prostate Cancer Patients. Cytometry, 62A: 46-53, 2004.
  4. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Rueben JM Doyle G, Allard WJ, Terstappen LWMM, Hayes DF. Circulating Tumor Cells, Disease Progression and Survival in Metastatic Breast Cancer. NEJM, 351, 781-791, 2004.
  5. Cristofanilli M, Terstappen LWMM, Hayes DF. Circulating Tumor Cells, Disease Progression and Survival in Metastatic Breast Cancer-Reply NEJM, 351, 2453-2454, 2004.
  6. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herylyn D, Terstappen LWMM, Fehm T, Tucker TF, Lane N, Uhr JW. Circulating Tumor Cells in Patients with Breast Cancer Dormancy. Clin Can Res, 10: 8152-8162, 2004.
  7. Allard W J, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe A, Uhr JW,Terstappen LWMM.Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Clin Can Res, 10: 6897-6904, 2004.
2003
  1. Christensen,B., Kolvraa,S., Lykke-Hansen,L., Lorch,T., Gohel,D. I., Smidt-Jensen,S., Bang,J., Philip,J. Studies on the isolation and identification of fetal nucleated red blood cells in the circulation of pregnant women before and after chorion villus sampling. Fetal Diagnosis & Therapy, (2003), 18(5), p376-384.
2002
  1. Terstappen, LWMM. Immunicon,s immunomagnetic technology-assay tutorial: Tools for drug optimization and clinical development 22; 36-36, 2002
  2. Kagan M, Howard D, Bendele T, Mayes J, Silvia J, Repollet M, Doyle J, Allard J, Tu N, Bui T, Russell T, Rao C, Hermann M, Rutner H, Terstappen LWMM. A Sample Preparation and Analysis System for Identification of Circulating Tumor Cells. J Clinical Ligand Assay 25: 104-110, 2002
  3. Arjan G.J. Tibbe, Bart G. de Grooth, Jan Greve, Gerald J. Dolan, Chandra. Rao, Leon W.M.M. Terstappen. Magnetic field design for selecting and aligning immunomagnetic labeled cells. Cytometry 47:163-172, 2002.
  4. Arjan G.J. Tibbe, Bart G. de Grooth, Jan Greve, Chandra Rao, Gerry J. Dolan, Leon W.M.M. Terstappen. Cell analysis system based on compact disk technology. Cytometry 47:173-182, 2002.
  5. Kagan M, Howard D, Bendele T, Rao C, Terstappen LWMM. Circulating Tumor Cells as Cancer Markers, A Sample Preparation and Analysis System, In Tumor Markers: Physiology, Pathobiology, technology and Clinical Applications, eds Diamandis E P, Fritsche HA, Lilja H, Chan DW,Schwartz M. AACCPress, Washington, pp 495-498, 2002.
  6. Arjan G.J. Tibbe, Bart G. de Grooth, Jan Greve, Gerry J. Dolan, Leon W.M.M. Terstappen. Implementation of imaging technique in celltracks. Cytometry 47:248-255, 2002.
  7. Kagan M, Trainer M, Bendele T, Rao C, Horton A, Tibbe A, Greve J, Terstappen LWMM. CellTracks Cell Analysis System for Rare Cell Detection. In: G.E. Cohn (ed), Clinical Diagnostic Systems: Technologies and Instrumentation, Vol 4625, pp 20-28, Washington: SPIE, 2002.
  8. Hayes DF, Walker TM, Singh B, Vitetta E S, Uhr JW, Gross S, Rao C, Doyle GV and Terstappen LWMM. Monitoring Expression of HER-2 on Circulating Epithelial Cells in Patients with advanced Breast Cancer. Int J of Oncology 21: 1111-1118, 2002.
2001
  1. Tibbe AGJ, de Grooth B, Greve J, Liberti PA, Dolan GJ, Terstappen LWMM Cell analysis system based on immuno-magnetic cell selection and alignment followed by immuno-fluorescent analysis using Compact Disk technologies. Cytometry 43:31-37 (2001).
  2. Moreno JG., O’Hara SM, Gross S, Doyle G, Fritsche H, Gomella LG, Terstappen LWMM Changes in circulating carcinoma cells in metastatic prostate cancer patients correlates with disease status. Urology 58: 386-392 (2001).
  3. Liberi PA, Rao CG, Terstappen LWMM. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magnetism and Magnetic Materials 225: 301-307 (2001).
2000
  1. Terstappen LWMM, Rao C, Gross S, Weiss A. Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. International Journal of Oncology,17: 573-578 (2000).
  2. Chen R, Nagarajan S, Prince GM, Maheshwari U, Terstappen LWMM, Kaplan DR, Gerson SL, Albert JM, Dunn DE, Lazerus H, Medof E. Impaired growth and elevated Fas receptor expression in PIGA+ stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest, 106: 689-696 (2000).
  3. Terstappen LWMM. Detection of infrequent cells in blood and bone marrow by flowcytometry. In: Hematopoietic Stem Cell Transplantation , Marcel Dekker Inc, Ho A., Haas R, Champlin RE. ed. 137-152, (2000).
1999
  1. Nagler A, Condiotti R, Rabinowitz R, Schlesinger M, Nguyen M, Terstappen LWMM. Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC). Medical Oncology 16: 177-187 (1999).
  2. Mangan KF, Leonardo J, Mullaney MT, Terstappen LWMM, Rao C, Liberti P. A rapid two-step method for elimination of bcl-2/IgH positive non-Hodgkin’s lymphoma cells from human blood or marrow stem cells, employing immunomagnetic purging with streptavidin-coated ferrofluids. Cytotherapy 1: 287-293 (1999).
  3. Tibbe AGJ, de Grooth B, Greve J, Liberti PA, Dolan GJ, Terstappen LWMM. Optical tracking and detection of immunomagnetically selected and aligned cells. Nature Biotechnology 17: 1210-1213 (1999).
1998
  1. Terstappen LWMM, Rao C, Gross S, Kotelnikov V, Racila E, Uhr J, Weiss A. Enumeration of epithelial derived tumor cells in peripheral blood. Vox Sanguinis, 74: 269-274 (1998).
  2. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LWMM, Uhr JW. Detection and characterization of carcinoma cells in the blood. PNAS 95: 4589-4594 (1998).
Before 1998
  1. Aasheim HC , Terstappen LWMM, T Logtenberg. Regulated expression of the Eph-Related Receptor Tyrosine Kinase Hek11 in early human B lymphopoiesis. BLOOD 90: 3613-3622 (1997).
  2. Ho AD, Young D, Maruyama M, Law P, Corringham ET, Mason JR, Oldham F, Mills B, Terstappen L, Lane TA. Mobilization and purification of CD34+ cells from normal donors regimens with G-CSF, GM-CSF, or a combination of both. Bone Marrow Transplantation 17: S34-37, (1996).
  3. Gahn B, Haase D, Unterhalt M, Drescher M, Schoch C, Fonatsch C, Terstappen LWMM, Hiddeman W, Buchner Th, Bennett JM, Wormann B. De novo AML with dysplastic hematopoeisis: cytogenetic and prognostic significance. Leukemia 10: 946-951 (1996).
  4. Olweus J, Terstappen LWMM. Lund-Johansen F, Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells. BLOOD 88: 1594-1607 (1996).
  5. Ho AD, Young D, Maruyama M, Corringham ET, Mason JR, Thompson P, Grenier K, Law P,Terstappen L, Lane TA. Pluripotent and lineage-committed CD34+ subsets mobilized by G-CSF, GM-CSF,versus a combination of both. Exp Hematology. 24: 1460-1468 (1996).
  6. Civin C I, Almeida-Porada G, Lee MJ, Terstappen LWMM, Zanjani ED. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. BLOOD 88: 4102-4109 (1996).
  7. Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo GR, Terstappen LWMM. The “common stem cell” hypothesis reevaluated: Human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. BLOOD 85:2422-2435, (1995).
  8. Prince GM, Nguyen M, Brodsky RA, Lazarus HM, Terstappen LWMM, Medof ME. Peripheral blood harvest of CD34+ hematopoietic precursors in paroxysmal nocturnal hemoglobinuria. BLOOD 85: 3381-3386, (1995).
  9. Waller EK, Huang S, Terstappen LWMM. Changes in growth properties of CD34+, CD38- bone marrow progenitors during fetal development. BLOOD 86:710-718, (1995).
  10. Lane TA, Law P, Maruyama M, Young D, Butgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD. Harvesting and enrichment of hematopoietic stem cells mobilized into the peripheral blood of normal donors by G-CSF or GM-CSF. BLOOD 85: 275-282 (1995).
  11. Olweus J, Lund-Johansen F, Terstappen LWMM. CD64 / FcgR1 is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells. BLOOD 85: 2402-2413, (1995).
  12. de Kruif J, Terstappen LWMM, Boel E, T Logtenberg. Rapid selection of cell subpopulations-specific human monoclonal antibody fragments from a synthetic phage antibody library. PNAS 92: 3938-3942 (1995).
  13. Moore T, Huang S, Terstappen LWMM, Bennett M, Kumar V. Expression of CD43 on murine and human pluripotent hematopoietic stem cells. J. Immunology. 153: 4978-4987 (1994).
  14. Huang S, Terstappen LWMM. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells.BLOOD 83: 1515-1526 (1994).
  15. Lund-Johansen F, Terstappen LWMM. Differential expression of cell adhesion molecules during granulocyte maturation. J.Leuk. Biol.54:47-55 (1993).
  16. Terstappen LWMM, Gandour D, Huang S, Lund -Johansen F, Manion K, Mickaels R, Nguyen M, Olweus J, Toepker S: Assessment of hematopoietic cell differentiation by multidimensional flow cytometry. J. Hematotherapy. 2: 431-477 (1993).
  17. Picker LJ, Treer JR, Nguyen M,Terstappen LWMM, Hogg N, Yednock T. Coordinate Expression of b1 and b2 Integrin "Activation" Epitopes During T Cell Responses in Secondary Lymphoid Tissue. Eur J Immunol. 23: 2751-2757 (1993).
  18. Wormann B, Safford M, Konemann S, Buchner T, Hiddemann W, Terstappen LW. Detection of aberrant antigen expression in acute myeloid leukemia by multiparameter flow cytometry. Recent Results Cancer Res 131:185-96 (1993).
  19. Terstappen LWMM, Huang S: Analysis of bone marrow stem cells. Blood Cells, 20: 45-63 (1994).
  20. Chia Huei Chen, Wendy Lin, Shou Shye, Ruth Kibler, Kathy Grenier, Diether Recktenwald, Leon WMM Terstappen. Automated enumeration of CD34+ cells in peripheral blood and bone marrow. J of Hematotherapy 3: 3-13 (1994).
  21. Terstappen LWMM, Lund-Johansen F. Hematopoietic progenitors in fetal and adult tissue. Blood Cells 20: 392-396 (1994).
  22. Olweus J, Lund-Johansen F, Terstappen LWMM. Cell surface antigen expression during early hematopoietic cell differentiation in adult and fetal bone marrow. Immunomethods 5: 179-188 (1994).
  23. Huang S, Terstappen LWMM Formation of both hematopoietic microenvironment and hematopoietic stem cells from single sorted human bone marrow stem cells. Nature, 360: 745-749 (1992). Correction: Nature, 368: 664 (1994).
  24. Wörmann B , Safford M, Könemann S, Zurlutter K, Piechotka K, Schreiber K, Loken MR, Sauerland C, Büchner Th, Hiddemann W, Terstappen LWMM.Prospective study on the clinical relevance of residual disease in patients with acute myeloid leukemia in complete remission. Hematology and Blood Transfusion 36:675-680, (1994)
  25. Picker LJ, Treer JR, Ferguson-Darnell B, Collins P, Buck D, Terstappen LWMM. Control of lymphocyte circulation in man: I Differential regulation of the peripheral lymph node homing receptor L-Selectin on T cells during the virgin to memory cell transition. J Immunology, 150: 1105-1121 (1993).
  26. Picker LJ, Treer JR, Ferguson-Darnell B, Collins P, Bergstresser PR, Terstappen LWMM. Control of lymphocyte circulation in man: II. Differential regulation of the cutaneous lymphocyte-associated antigen (CLA), a tissue-selective homing receptor for skin-homing T cells. J Immunology, 150: 1122-1136 (1993).
  27. Terstappen LWMM, Nguyen M, Huang S, Lazerus H, Medof E. Defective and normal hematopoietic stem cells in paroxysmal nocturnal hemoglobinuria. Br J Haematol, 84, 504-514 (1993).
  28. Verwer B, Terstappen LWMM. Automatic lineage assignment of acute leukemias by flow cytometry. Cytometry 14: 862-875 (1993).
  29. Reading C, Huh Y, Estey E, Claxton DF, Sanchez G, Terstappen L, O’Brien M, Baron S, Deisseroth A. Aberrant surface phenotype expression in acute myelogenous leukemia. BLOOD 81: 3083-3090 (1993).
  30. Collins RH, Anastasi J, Terstappen LWMM, Nikaein A, Fay JW, Klintmalm G. Donor-derived long-term multilineage hematopoiesis in a liver transplant recipient. N. Engl.J. Med. 328: 762-765 (1993).
  31. Terstappen LWMM, Loken MR. Leukocyte differential counting. Flowcytometry in hematology. Laereum O.D., Bjerknes R.(eds) Academic Press, London, 95-107 (1992).
  32. Terstappen LWMM, Huang S, Picker LJ. Flow cytometric assessment of human T-cell differentiation in thymus an bone marrow. BLOOD 79; 666-677 (1992).
  33. Terstappen LWMM, Safford M, Unterhalt M, Könemann S, Zurlutter K, Piechotka K, Drescher M, Aul C, Büchner Th, Hiddemann W, Wörmann B. Flow cytometric characterization of acute myeloid leukemias. IV. Comparison of the differentiation pathway of normal hematopoietic progenitor cells. Leukemia 6: 993-1001 (1992)
  34. Terstappen LWMM, Levin J. Bone marrow differential counts obtained by multidimensional flow cytometry. Blood Cells 18:311-330 (1992).
  35. Terstappen LWMM, Buescher S, Nguyen M, Reading C. Differentiation and maturation of growth factor expanded early human hematopoeitic progenitors assessed by multidimensional flow cytometry. Leukemia 6: 1001-1011 (1992).
  36. Terstappen LWMM, Nguyen M, Lazerus H, Medof E. Expression of DAF (CD55) and CD59 antigens during normal hematopoeitic cell differentiation. J Leuk Biol, 52: 652-660 (1992).
  37. Loken MR, Civin CI, Shah VO, MJ Fackler, Segers-Nolten I, Safford M, Terstappen LWMM. Flow cytometric characterization of erythroid, lymphoid and monomyeloid lineages in normal human bone marrow. Flowcytometry in hematology. Laereum O.D., Bjerknes R. (eds) Academic Press, London, 95-107 (1992).
  38. Terstappen LWMM, Könemann S, Safford M, Loken MR, Zurlutter K, Büchner Th, Hiddemann W, Wörmann B. Flow cytometric characterization of acute myeloid leukemias. I. Significance of light scattering properties. Leukemia 5; 315-321 (1991).
  39. Terstappen LWMM, Huang S, M Safford, Lansdorp PM,Loken MR. Sequential generations of hematopoietic colonies derived from single non lineage committed progenitor cells. BLOOD 77; 1218-1227 (1991).
  40. Terstappen LWMM, Johnson D, Mickaels RA, Chen J, Olds G, Hawkins JT, Loken MR, Levin J. Multidimensional flow cytometric blood cell differentiation without erythrocyte lysis. Blood Cells 17: 585-602 (1991).
  41. Terstappen LWMM, Safford M, Könemann S, Loken MR, Zurlutter K, Büchner Th, Hiddemann W, Wörmann B. Flow cytometric characterization of acute myeloid leukemias. II. Phenotypic heterogeneity at presentation. Leukemia 5; 757-767 (1991).
  42. Lansdorp PM, Smith C, M Safford, Terstappen LWMM, Thomas TE. Single laser three color immunofluorescence staining procedures based on energy transfer between phycoerythrin and cyanine 5. Cytometry 12; 723-730 (1991).
  43. Terstappen LWMM, Mickaels R, Dost R, Loken MR. Increased light scattering resolution facilitates multidimensional flow cytometric analysis. Cytometry 11; 506-512 (1990).
  44. Terstappen LWMM, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Analytical Cellular Pathology 2; 229-240 (1990).
  45. Terstappen LWMM, Johnsen S, Segers-Nolten I, Loken MR. Identification and characterization of normal human plasma cells by high resolution flow cytometry. BLOOD 76; 1739-1747 (1990).
  46. Terstappen LWMM, Safford M, Loken MR. Flow cytometric analysis of human bone marrow III. Neutrophil development. Leukemia 4; 657-663 (1990).
  47. Picker LJ, Terstappen LWMM, Rott LS, Streeter PR, Stein H, Butcher EC. Differential expression of homing-associated adhesion molecules by T-Cell subsets in man. J Immunology 145; 3247-3255 (1990).
  48. Terstappen LWMM, Z Hollander,Meiners H, Loken MR. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J of Leukocyte Biology 48: 138-148 (1990).
  49. Terstappen LWMM, de Grooth BG, Nolten GMJ, Greve J. Cytotoxic lymphocytes in B-cell chronic lymphocytic leukemia. A flow cytometric study of peripheral blood and bone marrow. Blut 60:81-87 (1990).
  50. Terstappen LWMM, Meiners H, Loken MR. A rapid sample preparation technique for flow cytometric analysis of immunofluorescence allowing absolute enumeration of cell subpopulations. J Immunol Methods 123; 103-112 (1989).
  51. Terstappen LWMM, de Grooth BG, Visscher K, van Kouterik FA, Greve J. Four-Parameter White Blood Cell Differential Counting Based on Light Scattering Measurements. Cytometry 9: 39-43 (1988).
  52. Terstappen LWMM, de Grooth BG, van Berkel W,ten Napel CHH, Greve J. Application of Orthogonal Light Scattering for Routine Screening of Lymphocyte Samples. Cytometry 9: 220-225 (1988).
  53. Terstappen LWMM. de Grooth BG, van Berkel W,ten Napel CHH, Greve J. Flow Cytometric Characterization of Chronic Lymphocyte Leukemias using Orthogonal Light Scattering and Quantitative Immunofluorescence. Blut 56: 201-208 (1988).
  54. Terstappen LWMM , de Grooth BG, van Berkel W,ten Napel CHH, Greve J. Abnormal distribution of CD8 subpopulation in B- Chronic Lymphocytic Leukemia identified by Flow Cytometry. Leukemia Research 12: 551-557 (1988).
  55. Terstappen LWMM , de Grooth BG, van Berkel W,ten Napel CHH, Greve J. The Effects of Splenic Irradiation on Lymphocyte Subpopulations in B-Chronic Lymphocytic Leukemia. Eur J of Haematol 41: 496-505 (1988).
  56. Terstappen LWMM, Shah VO., Conrad MP. ,Recktenwald, D., LokenMR. Discriminating between Damaged and Intact Cells in Fixed Flow Cytometric Samples. Cytometry 9: 477-484 (1988).
  57. Terstappen LWMM, Loken MR. 5 Dimensional Flow Cytometry as a New Approach for Blood and Bone Marrow Differentials. Cytometry 9: 548-556 (1988).
  58. Terstappen LWMM. Flow Cytometric Characterization of White Blood Cells of Healthy Donors and Patients with Lymphocytic Diseases. ISBN 90-9002197-3, June 1988 (Thesis).
  59. Terstappen LWMM, de Grooth BG, Nolten GMJ, ten Napel CHH, van Berkel W, GreveJ. Physical discrimination between human T lymphocyte subpopulations by means of Light Scattering, revealing two populations of T8-positive cells. Cytometry 7: 178-183 (1986).
  60. Terstappen LWMM, de Grooth BG, ten Napel CHH, van Berkel W, Greve J.Discrimination of Human Cytotoxic Lymphocytes from Regulatory and B-lymphocytes by Orthogonal Light Scattering. J Immunol Methods 95: 211-216 (1986).
  61. de Grooth BG, Terstappen LWMM, Puppels GJ, Greve J. Light-Scattering Polarization Measurements as a New Parameter in Flow Cytometry. Cytometry 8: 539-544 (1987).
  62. Terstappen LWMM, de Grooth BG, Nolten GMJ, ten Napel CHH, van Berkel W, GreveJ. Flow Cytometric determination of Circulating Immune Complexes with the Indirect Granulocyte Phagocytosis Test. Cytometry 6: 316-320 (1985).
  63. Terstappen LWMM , Arends RPJH, ten Napel CHH. Hereditair Lymfoedeem, een vaak miskende vorm van chronisch oedeem; Klinisch onderzoek bij 2 families met de ziekte van Meige.Ned. Tijdschrift. Geneesk. 129: 208-212 (1985).